표적 시퀀싱 및 리시퀀싱 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Targeted Sequencing And Resequencing Market size is expected to reach USD 68.64 Billion in 2034 from USD 10.57 Billion (2025) growing at a CAGR of 23.1% during 2026-2034.

The Global Targeted Sequencing and Resequencing Market is experiencing significant growth driven by advancements in genomics and personalized medicine. Increasing research activities in cancer diagnostics, rare diseases, and genetic disorders have accelerated the adoption of targeted sequencing technologies. The demand for cost-effective and accurate gene analysis tools is expanding across research institutions and clinical laboratories.

Growth drivers include declining sequencing costs, rising investment in biotechnology research, and the growing application of next-generation sequencing (NGS). Pharmaceutical companies are increasingly using targeted resequencing for drug discovery and development. The expanding focus on precision medicine and companion diagnostics is further strengthening market demand worldwide.

Looking forward, continuous technological innovation and integration of bioinformatics tools are expected to enhance data accuracy and processing speed. Emerging markets are likely to witness increased adoption due to improving healthcare infrastructure. With ongoing advancements in genomics research and rising awareness about genetic testing, the market holds strong long-term growth potential.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• Sequencing
• Re-Sequencing

By Application

• Clinical Application
• Plant And Animal Sciences
• Drug Development
• Others

By Type

• DNA-Based Targeted Sequencing
• RNA-Based Targeted Sequencing

By End-Use

• Hospitals & Clinics
• Academic Research
• Others

COMPANIES PROFILED

• Agilent Technologies, Illumina Inc, F HoffmannLa Roche Ltd, Thermo Fisher Scientific Inc, Dnastar Inc, PacBio, BioRad Laboratories Inc, Integrated DNA Technologies Inc, Perkin Elmer Inc, RainDance Technologies Inc, PierianDx
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Re-Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Clinical Application Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Plant And Animal Sciences Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Drug Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET: BY TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Type
• 6.2. DNA-Based Targeted Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. RNA-Based Targeted Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Academic Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Technology
  • 8.2.2 By Application
  • 8.2.3 By Type
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Technology
  • 8.3.2 By Application
  • 8.3.3 By Type
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Technology
  • 8.4.2 By Application
  • 8.4.3 By Type
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Technology
  • 8.5.2 By Application
  • 8.5.3 By Type
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Technology
  • 8.6.2 By Application
  • 8.6.3 By Type
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL TARGETED SEQUENCING AND RESEQUENCING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Agilent Technologies
  • 10.2.2 Illumina Inc
  • 10.2.3 F. Hoffmann-La Roche Ltd
  • 10.2.4 Thermo Fisher Scientific Inc
  • 10.2.5 Dnastar Inc
  • 10.2.6 PacBio
  • 10.2.7 Bio-Rad Laboratories Inc
  • 10.2.8 Integrated DNA Technologies Inc
  • 10.2.9 Perkin Elmer Inc
  • 10.2.10 RainDance Technologies Inc
  • 10.2.11 PierianDx